17th Jun 2008 15:46
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
All relevant boxes should be completed in block capital letters
|
1 |
Name of the Issuer UNITED DRUG PLC |
2 |
State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii) |
|
3 |
Name of PERSON DISCHARGING MANAGERIAL RESPONSIBILITY MR. LUKE BREHONY |
4 |
State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
|
5 |
Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE |
6 |
Description of shares (including class) debentures or derivatives or financial instruments relating to shares GRANTING OF STOCK OPTIONS RELATING TO ORDINARY SHARES OF €0.05 EACH |
|
7 |
Name of registered shareholder(s) and, if more than one, number of shares held by each of them N/A |
8 |
State the nature of the transaction GRANTING OF STOCK OPTIONS |
|
9 |
Number of shares, debentures or financial instruments relating to shares acquired N/A |
10 |
Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) N/A |
|
11 |
Number of shares, debentures or financial instruments relating to shares disposed N/A |
12 |
Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
|
13 |
Price per share or value of transaction N/A |
14 |
Date and place of transaction 17 JUNE 2008 |
|
15 |
Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/A |
16 |
Date issuer informed of transaction N/A |
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
|
17 |
Date of grant 17 JUNE 2008 |
18 |
Period during which or date on which it can be exercised 30,000 FROM 17 JUNE 2011 TO 16 JUNE 2018 40,000 FROM 17 JUNE 2013 TO 16 JUNE 2018 |
|
19 |
Total amount paid (if any) for grant of the option N/A |
20 |
Description of shares or debentures involved (class and number) ORDINARY SHARES OF €0.05 EACH |
|
21 |
Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise €3.83 |
22 |
Total number of shares or debentures over which options are held following notification 451,000 €0.05 ORDINARY SHARES |
|
23 |
Any additional information N/A |
24 |
Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
|
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 17/06/2008 |
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
All relevant boxes should be completed in block capital letters
|
1 |
Name of the Issuer UNITED DRUG PLC |
2 |
State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii) |
|
3 |
Name of DIRECTOR MR. CHRIS CORBIN |
4 |
State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
|
5 |
Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE |
6 |
Description of shares (including class) debentures or derivatives or financial instruments relating to shares GRANTING OF STOCK OPTIONS RELATING TO ORDINARY SHARES OF €0.05 EACH |
|
7 |
Name of registered shareholder(s) and, if more than one, number of shares held by each of them N/A |
8 |
State the nature of the transaction GRANTING OF STOCK OPTIONS |
|
9 |
Number of shares, debentures or financial instruments relating to shares acquired N/A |
10 |
Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) N/A |
|
11 |
Number of shares, debentures or financial instruments relating to shares disposed N/A |
12 |
Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
|
13 |
Price per share or value of transaction N/A |
14 |
Date and place of transaction 17 JUNE 2008 |
|
15 |
Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/A |
16 |
Date issuer informed of transaction N/A |
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
|
17 |
Date of grant 17 JUNE 2008 |
18 |
Period during which or date on which it can be exercised 45,000 FROM 17 JUNE 2011 TO 16 JUNE 2018 40,000 FROM 17 JUNE 2013 TO 16 JUNE 2018 |
|
19 |
Total amount paid (if any) for grant of the option N/A |
20 |
Description of shares or debentures involved (class and number) ORDINARY SHARES OF €0.05 EACH |
|
21 |
Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise €3.83 |
22 |
Total number of shares or debentures over which options are held following notification 736,000 €0.05 ORDINARY SHARES |
|
23 |
Any additional information N/A |
24 |
Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
|
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 17/06/2008 |
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
All relevant boxes should be completed in block capital letters
|
1 |
Name of the Issuer UNITED DRUG PLC |
2 |
State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii) |
|
3 |
Name of DIRECTOR MR. LIAM FITZGERALD |
4 |
State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
|
5 |
Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE |
6 |
Description of shares (including class) debentures or derivatives or financial instruments relating to shares GRANTING OF STOCK OPTIONS RELATING TO ORDINARY SHARES OF €0.05 EACH |
|
7 |
Name of registered shareholder(s) and, if more than one, number of shares held by each of them N/A |
8 |
State the nature of the transaction GRANTING OF STOCK OPTIONS |
|
9 |
Number of shares, debentures or financial instruments relating to shares acquired N/A |
10 |
Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) N/A |
|
11 |
Number of shares, debentures or financial instruments relating to shares disposed N/A |
12 |
Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
|
13 |
Price per share or value of transaction N/A |
14 |
Date and place of transaction 17 JUNE 2008 |
|
15 |
Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/A |
16 |
Date issuer informed of transaction N/A |
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
|
17 |
Date of grant 17 JUNE 2008 |
18 |
Period during which or date on which it can be exercised 100,000 FROM 17 JUNE 2011 TO 16 JUNE 2018 80,000 FROM 17 JUNE 2013 TO 16 JUNE 2018 |
|
19 |
Total amount paid (if any) for grant of the option N/A |
20 |
Description of shares or debentures involved (class and number) ORDINARY SHARES OF €0.05 EACH |
|
21 |
Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise €3.83 |
22 |
Total number of shares or debentures over which options are held following notification 1,343,000 €0.05 ORDINARY SHARES |
|
23 |
Any additional information N/A |
24 |
Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
|
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 17/06/2008 |
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
All relevant boxes should be completed in block capital letters
|
1 |
Name of the Issuer UNITED DRUG PLC |
2 |
State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii) |
|
3 |
Name of DIRECTOR MS. ANNETTE FLYNN |
4 |
State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
|
5 |
Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE |
6 |
Description of shares (including class) debentures or derivatives or financial instruments relating to shares GRANTING OF STOCK OPTIONS RELATING TO ORDINARY SHARES OF €0.05 EACH |
|
7 |
Name of registered shareholder(s) and, if more than one, number of shares held by each of them N/A |
8 |
State the nature of the transaction GRANTING OF STOCK OPTIONS |
|
9 |
Number of shares, debentures or financial instruments relating to shares acquired N/A |
10 |
Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) N/A |
|
11 |
Number of shares, debentures or financial instruments relating to shares disposed N/A |
12 |
Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
|
13 |
Price per share or value of transaction N/A |
14 |
Date and place of transaction 17 JUNE 2008 |
|
15 |
Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/A |
16 |
Date issuer informed of transaction N/A |
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
|
17 |
Date of grant 17 JUNE 2008 |
18 |
Period during which or date on which it can be exercised 45,000 FROM 17 JUNE 2011 TO 16 JUNE 2018 40,000 FROM 17 JUNE 2013 TO 16 JUNE 2018 |
|
19 |
Total amount paid (if any) for grant of the option N/A |
20 |
Description of shares or debentures involved (class and number) ORDINARY SHARES OF €0.05 EACH |
|
21 |
Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise €3.83 |
22 |
Total number of shares or debentures over which options are held following notification 425,000 €0.05 ORDINARY SHARES |
|
23 |
Any additional information N/a |
24 |
Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
|
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 17/06/2008 |
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
All relevant boxes should be completed in block capital letters
|
1 |
Name of the Issuer UNITED DRUG PLC |
2 |
State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii) |
|
3 |
Name of COMPANY SECRETARY MS. KAREN GEOGHEGAN |
4 |
State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
|
5 |
Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE |
6 |
Description of shares (including class) debentures or derivatives or financial instruments relating to shares GRANTING OF STOCK OPTIONS RELATING TO ORDINARY SHARES OF €0.05 EACH |
|
7 |
Name of registered shareholder(s) and, if more than one, number of shares held by each of them N/A |
8 |
State the nature of the transaction GRANTING OF STOCK OPTIONS |
|
9 |
Number of shares, debentures or financial instruments relating to shares acquired N/A |
10 |
Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) N/A |
|
11 |
Number of shares, debentures or financial instruments relating to shares disposed N/A |
12 |
Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
|
13 |
Price per share or value of transaction N/A |
14 |
Date and place of transaction 17 JUNE 2008 |
|
15 |
Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/A |
16 |
Date issuer informed of transaction N/A |
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
|
17 |
Date of grant 17 JUNE 2008 |
18 |
Period during which or date on which it can be exercised 35,000 FROM 17 JUNE 2011 TO 16 JUNE 2018 5,000 FROM 17 JUNE 2013 TO 16 JUNE 2018 |
|
19 |
Total amount paid (if any) for grant of the option N/A |
20 |
Description of shares or debentures involved (class and number) ORDINARY SHARES OF €0.05 EACH |
|
21 |
Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise €3.83 |
22 |
Total number of shares or debentures over which options are held following notification 65,000 €0.05 ORDINARY SHARES |
|
23 |
Any additional information N/a |
24 |
Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
|
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 17/06/2008 |
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
All relevant boxes should be completed in block capital letters
|
1 |
Name of the Issuer UNITED DRUG PLC |
2 |
State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii) |
|
3 |
Name of PERSON DISCHARGING MANAGERIAL RESPONSIBILITY MR. LIAM LOGUE |
4 |
State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
|
5 |
Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE |
6 |
Description of shares (including class) debentures or derivatives or financial instruments relating to shares GRANTING OF STOCK OPTIONS RELATING TO ORDINARY SHARES OF €0.05 EACH |
|
7 |
Name of registered shareholder(s) and, if more than one, number of shares held by each of them N/A |
8 |
State the nature of the transaction GRANTING OF STOCK OPTIONS |
|
9 |
Number of shares, debentures or financial instruments relating to shares acquired N/A |
10 |
Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) N/A |
|
11 |
Number of shares, debentures or financial instruments relating to shares disposed N/A |
12 |
Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
|
13 |
Price per share or value of transaction N/A |
14 |
Date and place of transaction 17 JUNE 2008 |
|
15 |
Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/A |
16 |
Date issuer informed of transaction N/A |
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
|
17 |
Date of grant 17 JUNE 2008 |
18 |
Period during which or date on which it can be exercised 45,000 FROM 17 JUNE 2011 TO 16 JUNE 2018 30,000 FROM 17 JUNE 2013 TO 16 JUNE 2018 |
|
19 |
Total amount paid (if any) for grant of the option N/A |
20 |
Description of shares or debentures involved (class and number) ORDINARY SHARES OF €0.05 EACH |
|
21 |
Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise €3.83 |
22 |
Total number of shares or debentures over which options are held following notification 340,000 €0.05 ORDINARY SHARES |
|
23 |
Any additional information N/a |
24 |
Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
|
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 17/06/2008 |
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
All relevant boxes should be completed in block capital letters
|
1 |
Name of the Issuer UNITED DRUG PLC |
2 |
State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii) |
|
3 |
Name of DIRECTOR MR. BARRY MCGRANE |
4 |
State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
|
5 |
Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE |
6 |
Description of shares (including class) debentures or derivatives or financial instruments relating to shares GRANTING OF STOCK OPTIONS RELATING TO ORDINARY SHARES OF €0.05 EACH |
|
7 |
Name of registered shareholder(s) and, if more than one, number of shares held by each of them N/A |
8 |
State the nature of the transaction GRANTING OF STOCK OPTIONS |
|
9 |
Number of shares, debentures or financial instruments relating to shares acquired N/A |
10 |
Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) N/A |
|
11 |
Number of shares, debentures or financial instruments relating to shares disposed N/A |
12 |
Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
|
13 |
Price per share or value of transaction N/A |
14 |
Date and place of transaction 17 JUNE 2008 |
|
15 |
Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/A |
16 |
Date issuer informed of transaction N/A |
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
|
17 |
Date of grant 17 JUNE 2008 |
18 |
Period during which or date on which it can be exercised 50,000 FROM 17 JUNE 2011 TO 16 JUNE 2018 40,000 FROM 17 JUNE 2013 TO 16 JUNE 2018 |
|
19 |
Total amount paid (if any) for grant of the option N/A |
20 |
Description of shares or debentures involved (class and number) ORDINARY SHARES OF €0.05 EACH |
|
21 |
Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise €3.83 |
22 |
Total number of shares or debentures over which options are held following notification 798,500 €0.05 ORDINARY SHARES |
|
23 |
Any additional information N/A |
24 |
Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
|
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 17/06/2008 |
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
All relevant boxes should be completed in block capital letters
|
1 |
Name of the Issuer UNITED DRUG PLC |
2 |
State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii) |
|
3 |
Name of PERSON DISCHARGING MANAGERIAL RESPONSIBILITY MR. SEAN QUIGLEY |
4 |
State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
|
5 |
Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE |
6 |
Description of shares (including class) debentures or derivatives or financial instruments relating to shares GRANTING OF STOCK OPTIONS RELATING TO ORDINARY SHARES OF €0.05 EACH |
|
7 |
Name of registered shareholder(s) and, if more than one, number of shares held by each of them N/A |
8 |
State the nature of the transaction GRANTING OF STOCK OPTIONS |
|
9 |
Number of shares, debentures or financial instruments relating to shares acquired N/A |
10 |
Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) N/A |
|
11 |
Number of shares, debentures or financial instruments relating to shares disposed N/A |
12 |
Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
|
13 |
Price per share or value of transaction N/A |
14 |
Date and place of transaction 17 JUNE 2008 |
|
15 |
Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/A |
16 |
Date issuer informed of transaction N/A |
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
|
17 |
Date of grant 17 JUNE 2008 |
18 |
Period during which or date on which it can be exercised 40,000 FROM 17 JUNE 2011 TO 16 JUNE 2018 40,000 FROM 17 JUNE 2013 TO 16 JUNE 2018 |
|
19 |
Total amount paid (if any) for grant of the option N/A |
20 |
Description of shares or debentures involved (class and number) ORDINARY SHARES OF €0.05 EACH |
|
21 |
Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise €3.83 |
22 |
Total number of shares or debentures over which options are held following notification 245,000 €0.05 ORDINARY SHARES |
|
23 |
Any additional information N/A |
24 |
Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
|
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 17/06/2008 |
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
All relevant boxes should be completed in block capital letters
|
1 |
Name of the Issuer UNITED DRUG PLC |
2 |
State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii) |
|
3 |
Name of PERSON DISCHARGING MANAGERIAL RESPONSIBILITY MR. ALAN RALPH |
4 |
State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
|
5 |
Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE |
6 |
Description of shares (including class) debentures or derivatives or financial instruments relating to shares GRANTING OF STOCK OPTIONS RELATING TO ORDINARY SHARES OF €0.05 EACH |
|
7 |
Name of registered shareholder(s) and, if more than one, number of shares held by each of them N/A |
8 |
State the nature of the transaction GRANTING OF STOCK OPTIONS |
|
9 |
Number of shares, debentures or financial instruments relating to shares acquired N/A |
10 |
Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) N/A |
|
11 |
Number of shares, debentures or financial instruments relating to shares disposed N/A |
12 |
Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
|
13 |
Price per share or value of transaction N/A |
14 |
Date and place of transaction 17 JUNE 2008 |
|
15 |
Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/A |
16 |
Date issuer informed of transaction N/A |
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
|
17 |
Date of grant 17 JUNE 2008 |
18 |
Period during which or date on which it can be exercised 55,000 FROM 17 JUNE 2011 TO 16 JUNE 2018 45,000 FROM 17 JUNE 2013 TO 16 JUNE 2018 |
|
19 |
Total amount paid (if any) for grant of the option N/A |
20 |
Description of shares or debentures involved (class and number) ORDINARY SHARES OF €0.05 EACH |
|
21 |
Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise €3.83 |
22 |
Total number of shares or debentures over which options are held following notification 498,500 €0.05 ORDINARY SHARES |
|
23 |
Any additional information N/A |
24 |
Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
|
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 17/06/2008 |
Related Shares:
UDG.L